| First Author | Kolodziejczyk SM | Year | 2001 |
| Journal | Curr Biol | Volume | 11 |
| Issue | 16 | Pages | 1278-82 |
| PubMed ID | 11525743 | Mgi Jnum | J:71463 |
| Mgi Id | MGI:2150204 | Doi | 10.1016/s0960-9822(01)00397-9 |
| Citation | Kolodziejczyk SM, et al. (2001) Activation of JNK1 contributes to dystrophic muscle pathogenesis. Curr Biol 11(16):1278-82 |
| abstractText | Duchenne Muscular Dystrophy (DMD) originates from deleterious mutations in the dystrophin gene, with a complete loss of the protein product [1, 2]. Subsequently, the disease is manifested in severe striated muscle wasting and death in early adulthood [3]. Dystrophin provides a structural base for the assembly of an integral membrane protein complex [4]. As such, dystrophin deficiency leads to an altered mechanical integrity of the myofiber and a predisposition to contraction-induced damage [5-7]. However, the development of myofiber degeneration prior to an observed mechanical defect has been documented in various dystrophic models [8, 9]. Although activation of a detrimental signal transduction pathway has been suggested as a probable cause, a specific cellular cascade has yet to be defined. Here, it is shown that murine models of DMD displayed a muscle-specific activation of JNK1. Independent activation of JNK1 resulted in defects in myotube viability and integrity in vitro, similar to a dystrophic phenotype. In addition, direct muscle injection of an adenoviral construct containing the JNK1 inhibitory protein, JIP1, dramatically attenuated the progression of dystrophic myofiber destruction. Taken together, these results suggest that a JNK1-mediated signal cascade is a conserved feature of dystrophic muscle and contributes to the progression of the disease pathogenesis. |
